Oct 17, 2019 | Local, Regional
RI Bio has partnered with non-dilutive funding and government affairs experts, G2G to provide support and monthly reports on non-dilutive financing and government funding for entrepreneurs and researchers running startups in Rhode Island. G2G was founded by Liz...
Oct 17, 2019 | Local, Uncategorized
Patrice Milos, PhD, has been appointed as the new board chair for RI Bio. Dr. Milos is the president/CEO and co-founder of Medley Genomics, a life sciences company dedicated to addressing the challenges of genomic heterogeneity in the diagnosis and treatment of...
Sep 9, 2019 | Local, Regional
In her role as RI Bio’s executive director, Carol Malysz oversees the group’s coordination with health care organizations, life sciences companies, academic centers and others. RI Bio, along with the Rhode Island-Israel Collaborative, will present an event,...
Sep 5, 2019 | Local, National, Regional
Semma’s unique investigational approach combines robust production process of pancreatic islet cells with proprietary delivery system to restore insulin secretion in type 1 diabetes patients- -Semma to be acquired for $950 million in cash September 03, 2019...
Aug 16, 2019 | Local, National, Regional
RHODE ISLAND: A LEADING BIO HUB When people think of “Pharm Country”—the U.S. hotbed of biotechnology, pharmaceutical and medical companies in the Northeast—New Jersey, New York and Pennsylvania tend to come to mind first, given the presence of mammoth organizations...
